"Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19": Comment from Wada et al
- PMID: 35968794
- PMCID: PMC9537868
- DOI: 10.1111/jth.15791
"Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19": Comment from Wada et al
Figures
Comment in
-
"Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19": Reply.J Thromb Haemost. 2022 Sep;20(9):2161-2163. doi: 10.1111/jth.15790. J Thromb Haemost. 2022. PMID: 35968795 Free PMC article. No abstract available.
Comment on
-
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19.J Thromb Haemost. 2022 Feb;20(2):434-448. doi: 10.1111/jth.15575. Epub 2021 Nov 16. J Thromb Haemost. 2022. PMID: 34710269 Free PMC article.
References
-
- Berlin D.A., Gulick R.M., Martinez F.J. Severe COVID‐19. N Engl J Med. 2020;383:2451–2460. - PubMed
-
- Suzuki‐Inoue K., Fuller G.L., Garcia A., et al. A novel Syk‐dependent mechanism of platelet activation by the C‐type lectin receptor sCLEC‐2. Blood. 2006;107:542–549. - PubMed
-
- Yamashita Y., Suzuki K., Mastumoto T., et al. Elevated plasma levels of soluble C‐type lectin‐like receptor 2 (CLEC2) in patients with thrombotic microangiopathy. Thromb Res. 2019;178:54–58. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
